Evidence map›Paper›PMID 36136336›Full record

ArticleJAMA network open2022

Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic.

Jonathan H Cantor, Christopher M Whaley, Bradley D Stein, David Powell

Abstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan H CantorDepartment of Healthcare Delivery, RAND Corporation, Santa Monica, California.
Christopher M WhaleyDepartment of Healthcare Delivery, RAND Corporation, San Francisco, California.
Bradley D SteinDepartment of Healthcare Delivery, RAND Corporation, Pittsburgh, Pennsylvania.
David PowellDepartment of Healthcare Delivery, RAND Corporation, Santa Monica, California.

Funding

Quality of Medication Treatment for Opioid Use Disorder in Medicaid-enrollees: The Effects of State Policies and IntiativesR01DA045800 · NIDA · RAND CORPORATION · PI STEIN, BRADLEY D · 2018 to 2022
$2.9M
Improving Naloxone Access and Its Effects on Drug Abuse and OverdosesR01CE002999 · CE · RAND CORPORATION · PI POWELL, DAVID · 2018 to 2020
$1.9M
The Effects of Insurance Benefit Design Innovation on Patient HealthK01AG061274 · NIA · RAND CORPORATION · PI WHALEY, CHRISTOPHER · 2019 to 2023
$649k
NCIPC CDC HHS R01 CE002999NIA NIH HHS K01 AG061274NIDA NIH HHS R01 DA045800
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Substance-Related DisordersEthnicityHumansPandemicsSARS-CoV-2

Identifiers

PMID36136336
PMCPMC9500559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.